Cargando…
Molecular biology of neurodegenerative diseases : visions for the future. Part A /
"Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Volume 168 in the Progress in Molecular Biology and Translational Science series, provides the most topical, informative and exciting monographs available on a wide variety of research topics. The series includes in-depth...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam, The Netherlands :
Elsevier Academic Press,
2019.
|
| Edición: | First edition. |
| Colección: | Progress in molecular biology and translational science ;
v. 168. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Preface / David B. Teplow
- Section I: Targetting AD. Chapter One. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings / Kaj Blennow, Henrik Zetterberg
- Chapter Two. Tracking down a missing trigger for Alzheimer's disease by mass spectrometric imaging based on brain network analysis / Minako Hoshi
- Chapter Three. Using mirror-image peptides to enhance robustness and reproducibility in studying the amyloid [beta]-protein / Ariel J. Kuhn, Jevgenij A. Raskatov
- Section II: Etiology of AD. Chapter Four. In search of pathogenic amyloid [beta]-peptide in familial Alzheimer's disease / Michael S. Wolfe
- Chapter Five. Biology of splicing in Alzheimer's disease research / Kenichi Nagata, Takashi Saito, Takaomi C. Saido, Takashi Morihara
- Chapter Six. Acquired cerebral amyloid angiopathy: an emerging concept / Masahito Yamada, Tsuyoshi Hamaguchi, Kenji Sakai
- Section III: Neuroimmunology of AD. Chapter Seven. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease / Goran �Simi�c, Ena �Spani�c, Lea Langer Horvat, Patrick R. Hof
- Chapter Eight. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease / Susan Westfall, Umar Iqbal, Maria Sebastian, Giulio Maria Pasinetti
- Chapter Nine. Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges? / Stefan Prokop, Virginia M.Y. Lee, John Q. Trojanowski
- Section IV: AD therapy. Chapter Ten. Alzheimer's therapy development: a few points to consider / Einar M. Sigurdsson
- Chapter Eleven. The next steps in curing Alzheimer's disease / Fred W. van Leeuwen
- Chapter Twelve. Future horizons in Alzheimer's disease research / Thomas Wisniewski, Eleanor Drummond
- Chapter Thirteen. Why delay in effective treatment for Alzheimer's disease and related conditions / Khalid Iqbal, Fei Liu, ChengXin Gong, Chunling Dai, Wen Hu
- Chapter Fourteen. Restoring synaptic function through multimodal therapeutics / Raul Loera-Valencia, Muhammad-Al-Mustafa Ismail, Per Nilsson, Bengt Winblad
- Chapter Fifteen. Disease-modifying therapy for proteinopathies: can the exception become the rule? / Gal Bitan
- Chapter Sixteen. Combination therapy for Alzheimer's disease and related dementias / Martin M. Bednar
- Section V: Alpha-synucleinopathies. Chapter Seventeen. Can infections trigger alpha-synucleinopathies? / Christopher T. Tulisiak, Gabriela Mercado, Wouter Peelaerts, Lena Brundin, Patrik Brundin
- Chapter Eighteen. Prion-like propagation of [alpha]-synuclein in neurodegenerative diseases / Airi Tarutani, Masato Hasegawa
- Section VI: Model systems. Chapter Nineteen. Yeast models of neurodegenerative diseases / Mick F. Tuite.